SEC Form 4 · accession 0001645470-19-000009
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Feb 6, 2019
Accepted (ET)
Feb 11, 2019 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 6, 2019 | P | 5,000 | $0.0266 | A | 21,098,623 | D | |
| Common Stock | Feb 6, 2019 | P | 5,000 | $0.0259 | A | 21,103,623 | D | |
| Common Stock | Feb 6, 2019 | P | 5,000 | $0.0259 | A | 21,108,623 | D | |
| Common Stock | Feb 7, 2019 | P | 1,000 | $0.0262 | A | 21,109,623 | D | |
| Common Stock | Feb 7, 2019 | P | 5,000 | $0.0258 | A | 21,114,623 | D | |
| Common Stock | Feb 7, 2019 | P | 10,000 | $0.0257 | A | 21,124,623 | D | |
| Common Stock | Feb 7, 2019 | P | 5,000 | $0.0258 | A | 21,129,623 | D | |
| Common Stock | Feb 7, 2019 | P | 1,000 | $0.0259 | A | 21,130,623 | D | |
| Common Stock | Feb 7, 2019 | P | 1,000 | $0.0257 | A | 21,131,623 | D |
Table II — derivative securities
No Table II lines on this filing.